Servier Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Servier Pharmaceuticals's estimated annual revenue is currently $205.4M per year.
- Servier Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Servier Pharmaceuticals has 1022 Employees.
- Servier Pharmaceuticals grew their employee count by 5% last year.
Servier Pharmaceuticals's People
Name | Title | Email/Phone |
---|
Servier Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Servier Pharmaceuticals?
Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients' lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to serve patient needs and strives to provide future generations with a world where quality healthcare is available and accessible to all.
keywords:N/AN/A
Total Funding
1022
Number of Employees
$205.4M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Servier Pharmaceuticals News
Servier Pharmaceuticals LLC is a commercial-stage company with a passion for innovation and improving the lives of patients, their families...
(Funded by Agios Pharmaceuticals and Servier Pharmaceuticals; AGILE ClinicalTrials.gov number, NCT03173248. opens in new tab.)...
The study was funded by Agios Pharmaceuticals. Servier Pharmaceuticals has completed the acquisition of the Agios oncology business.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $301.1M | 1024 | 6% | N/A |
#2 | $183M | 1035 | 4% | $323.2M |
#3 | $328.9M | 1035 | -3% | N/A |
#4 | $363.3M | 1038 | -6% | N/A |
#5 | $211.8M | 1058 | 1% | $1000M |